Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2 NS) for Ovarian Cancer Therapy

High-grade serous ovarian cancer (HGSOC) is one of the major life-threatening cancers in women, with a survival rate of less than 50%. So far, chemotherapy is the main therapeutic tool to cure this lethal disease; however, in many cases, it fails to cure HGSOC even with severe side effects. Self-therapeutic nanomaterials could be an effective alternative to chemotherapy, facilitated by their diverse physicochemical properties and the ability to generate reactive species for killing cancer cells. Herein, inorganic cobalt hydroxide nanosheets (Co(OH)(2) NS) were synthesized by a simple solution process at room temperature, and morphological, spectroscopic, and crystallographic analyses revealed the formation of Co(OH)(2) NS with good crystallinity and purity. The as-prepared Co(OH)(2) NS showed excellent potency, comparable to the FDA-approved cisplatin drug to kill ovarian cancer cells. Flow cytometric analysis (nnexin V) revealed increased cellular apoptosis for Co(OH)(2) NS than cobalt acetate (the precursor). Tracking experiments demonstrated that Co(OH)(2) NS are internalized through the lysosome pathway, although relocalization in the cytoplasm has been observed. Hence, Co(OH)(2) NS could be an effective self-therapeutic drug and open up an area for the optimization of self-therapeutic properties of cobalt nanomaterials for cancer treatment.

Automated summary

High-grade serous ovarian cancer (HGSOC) is a major life-threatening cancer in women, with chemotherapy being the main therapeutic tool. However, the synthesized inorganic cobalt hydroxide nanosheets (Co(OH)(2) NS) show promising potency in killing ovarian cancer cells, potentially serving as an effective self-therapeutic drug.